Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 24, 2013

Primary Completion Date

November 8, 2016

Study Completion Date

November 8, 2016

Conditions
Acute Myeloid Leukemia
Interventions
DRUG

Pracinostat

Elderly newly diagnosed patients will all receive pracinostat

DRUG

Azacitidine

Elderly newly diagnosed patients will all receive azacitadine

Trial Locations (17)

29425

Medical College of South Carolina-Hollings Cancer Ctr, Charleston

30322

Emory University, Atlanta

46202

Inidana Univ Simon Cancer Center, Indianapolis

53226

Medical College of Wisconsin-Froedtert Cancer Center, Milwaukee

55905

Mayo Clinic, Rochester

60637

The University of Chicago, Chicago

65807

Mercy Medical Research Center, Springfield

66205

University of Kansas Cancer Center, Westwood

77030

MD Anderson, Houston

90033

USC Norrris Cancer Center, Los Angeles

91010

City of Hope Comprehensive Cancer Ctr, Duarte

94523

Bay Area Cancer Research Group, Pleasant Hill

97239

Oregon Health and Science University, Portland

94305-5821

Stanford University School of Medicine, Stanford

68198-7680

University of Nebraska Medical Center, Omaha

08103

Cooper Hospital, Camden

75390-9179

UT Southwestern Medical Center at Dallas, Dallas

Sponsors
All Listed Sponsors
lead

Helsinn Healthcare SA

INDUSTRY